{"id":"W2890837529","doi":"10.1111/jdv.15242","title":"Long‐term safety profile of ixekizumab in patients with moderate‐to‐severe plaque psoriasis: an integrated analysis from 11 clinical trials","year":2018,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Plaque psoriasis; Psoriasis; Clinical trial; Term (time); Safety profile; Dermatology; Internal medicine; Adverse effect; Psoriatic arthritis; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02100773,0.0007775879,0.003867322,0.001330737,0.0003339741,0.002322807,0.0006208349,0.0009449076,0.001281724],"category_scores_gemma":[0.01261216,0.0004394653,0.006122096,0.002133194,0.0005002083,0.0009416514,0.0007815843,0.001156769,0.0001794239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000878309,"about_ca_system_score_gemma":0.001208231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002743626,"about_ca_topic_score_gemma":0.0008904685,"domain_scores_codex":[0.9898292,0.004975277,0.001851173,0.001104082,0.001830765,0.0004094668],"domain_scores_gemma":[0.9795575,0.008942077,0.008214367,0.001031758,0.001447423,0.000806945],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.2062875,0.001938248,0.3338943,0.02344471,0.2204642,0.000553665,0.0004005954,0.00406925,0.007932994,0.0002704803,0.002476217,0.1982679],"study_design_scores_gemma":[0.05515302,0.05236859,0.6818042,0.003725157,0.1890242,0.00177421,0.0002455753,0.00182641,0.002100521,0.0005121803,0.01129678,0.0001691896],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7589597,0.2308633,0.00153303,0.0004729837,0.00007004169,0.001690463,0.004099257,0.0000552681,0.002256098],"genre_scores_gemma":[0.9594846,0.03318125,0.001389279,0.0004830053,0.0001237334,0.0008519987,0.004193689,0.00001964038,0.0002728002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02100773,"threshold_uncertainty_score":0.1111009,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03878062737402969,"score_gpt":0.3123729353849405,"score_spread":0.2735923080109108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}